Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results

Company Overview - Legend Biotech Corporation is a global leader in cell therapy with over 2,600 employees, making it the largest standalone cell therapy company [3] - The company is pioneering treatments that aim to revolutionize cancer care, particularly through its CAR-T cell therapy, CARVYKTI, which is a one-time treatment for relapsed or refractory multiple myeloma [3] - Legend Biotech collaborates with Johnson & Johnson for the development and marketing of CARVYKTI and is focused on maximizing patient access and therapeutic potential [3] Upcoming Events - Legend Biotech will host a conference call for investors on August 11, 2025, at 8:00 am ET to review its second-quarter 2025 results [1] - Senior leaders will provide an overview of the company's performance during the quarter [1] - A replay of the webcast and earnings news release will be available approximately two hours after the call concludes [2]